
GI Medical Oncologist @UHhospitals Seidman Cancer Center @caseccc. Hematology/Oncology & IM trained via @ClevelandClinic. IUSM grad. Tweets are my own.
Cleveland, OH
Joined August 2021
- Tweets2.1K
- Following1.1K
- Followers1.1K
- Likes61.8K
Madison Conces, MD retweeted
Hepatitis B and C, heavy alcohol use, and fatty liver disease all raise the risk of liver cancer, and some of those risks can be lowered. For #LiverCancerAwarenessMonth, @theNCI has plain-language information on risk and options: cancer.gov/types/liver
Madison Conces, MD retweeted
PRABITAS phase III trial pragmatic trial enrolled 972 pts in 17M evaluating the schedule of TAS-102 + bev (2 weeks on/2 weeks off) vs. (1 week on/1 week off) which validates non-inferiority and less dose reductions validating our RWD approach in the US. #colorectal #cancer #ESMO2026 @OncoAlert
Madison Conces, MD retweeted
Phase I encouraging results with INCB161734 (#KRAS #G12D) inhibitor 1200 mg + cetuximab (N=25) in #colorectal #cancer
- No grade 4/5 SAE's
- ORR = 36%
- DOR = 100%
- Median PFS = 7.2M
#ESMO2026 #RAS @Incyte @OncoAlert
Madison Conces, MD retweeted
Biweekly vs conventional trifluridine/tipiracil plus bevacizumab for refractory mCRC: The pragmatic ph 3 PRABITAS trial
#ESMO26 #ESMOAmbassadors
👉ORR: 2 vs 2%
👉 mPFS: 3.9 vs 3.9 mo
👉 mOS: 10.3 vs 11.3 mo
🧐similar efficacy, less toxicity, supports biweekly schedule
@myESMO @ASCO
Madison Conces, MD retweeted
#ESMO26 | LBA31
PRABITAS: Pragmatic Ph3 biweekly FTD/TPI + bev vs conventional FTD/TPI + bev in mCRC (non-inferiority)
▪️OS: 11.3 vs 10.3 mo, HR 0.93, 95% CI 0.80-1.08 (<1.25)
▪️PFS: 3.9 vs 3.9 mo, HR 0.93, 95% CI 0.81-1.06
▪️Safety
- ≥G3 neutropenia: 13% vs 39%
- FN: 1% vs 5%
- ≥G2 anorexia: 15% vs 26%
👉Biweekly FTD/TPI + bev showed non-inferior OS with less toxicities!
@myESMO @OncoAlert
Madison Conces, MD retweeted
NICHE-2 | 5-year results
Just 2 doses of neoadjuvant nivo + 1 dose of ipi, followed by surgery...
Not a single recurrence after nearly 5 years of follow-up, and 5-year OS was 100%!
What more could we ask for?
I'm truly at a loss for words👏
thelancet.com/journals/lance…
Madison Conces, MD retweeted
This #NationalDisabilityEmploymentAwarenessMonth, we're celebrating Elizabeth Bryson, a PhD candidate at @CWRUSOM whose IBD research is advancing potential new therapies while helping make science more accessible and inclusive. Read more: ms.spr.ly/6010aaQln
Madison Conces, MD retweeted
“It’s been a journey” Shroff told @NBCNews. “I’ve spent my entire life trying to eradicate cancer, primarily pancreatic cancer, but also liver cancers.”
nbcnews.com/health/disease/r…
An homage to Rachna Shroff, including thoughts from her family. Please read, share & honor her memory.
Madison Conces, MD retweeted
It has been a difficult week processing it all.
Rachna truly reflected the best of us & her
legacy will live on in the patients she cared for,
the trainees she mentored, the colleagues she
brought together & everyone she inspired
She always did what all stars do best…Shine
We join the oncology community in mourning the passing of Dr. Rachna T. Shroff, a renowned GI cancers expert and a dedicated ASCO volunteer. We are humbled by her dedication and strive to honor her legacy of commitment and altruism.
Read more: bit.ly/4e7jBKu
Madison Conces, MD retweeted
There is an especially outlandish conspiracy theory that oncologists are hiding the cure for cancer
Its proponents must think us particularly noble, then, when we sacrifice our lives to keep the secret: forgoing a panacea and succumbing to the very disease we treat
Dr. Shroff is not the only “wounded healer” I’ve known, but her legacy is far more than the wretched illness that claimed her own life too soon
She did her very best to push oncology forward, especially for patients with notoriously difficult-to-treat biliary tract cancers (a close relative, anatomically and sometimes pathophysiologically, to pancreatic adenocarcinoma)
I remember her incredible humility to stand at the podium at one of our largest scientific conferences and admit that a triplet therapy had not produced the benefits she had hoped for, allowing biological plausibility to cede to data yielded from the clinical trial she conceived & ran
Our field is full of such examples of good ideas failing to reach fruition, but we can only get better by admitting what’s not working as well as promoting true advances
When the history books are written, most, if not all chemo will look like grand folly, akin to our modern view of, say, blood-letting
But it is because of visionary physician-scientists like Rachna that we are making any progress at all: doing the best we can today while realizing there must be a better way and testing rigorously our ideas of how we might get there
May she be remembered in part for her tireless work, born out of irrepressible hope and true caring for her own patients as well as ones she never met (she never failed to kindly & helpfully answer a question I posed to her when I faced a management conundrum in her niche of cholangiocarcinoma)
RIP to a dear colleague (link in post below to a fund for young investigators named & bestowed in her honor)
We join the oncology community in mourning the passing of Dr. Rachna T. Shroff, a renowned GI cancers expert and a dedicated ASCO volunteer. We are humbled by her dedication and strive to honor her legacy of commitment and altruism.
Read more: bit.ly/4e7jBKu
Madison Conces, MD retweeted
It is with heavy hearts that we share that Dr. Rachna Shroff has passed away. A longtime partner of CCF, she has made tangible differences for patients and their families throughout her career. From being a valued member of our Science and Medical Advisory Board to helping build one of the nation's largest clinical and research programs in biliary tract cancer as a faculty member at MD Anderson Cancer Center, and as an empathetic and expert clinician, she made a difference in every facet.
Beyond her professional accomplishments, she brought fun everywhere she went. Whether she was quoting Beyoncé in a talk about clinical trials or getting us to throw our hands during her amazing Bollywood lesson, Rachna made us live in the moment and laugh, even in the hardest of times. Our hearts are with her family and friends in the days ahead and beyond.
Madison Conces, MD retweeted
Beyond devastating. Rachna was a friend to all oncologists, well known in @ASCO circles. We will all miss her. Her legacy lives on in the YIA endowed in her name.
@DrChoueiri @montypal @ERPlimackMD @aparna1024 @ErikaHamilton9
medicine.arizona.edu/news/20…
Unbelievable loss. 💔
Thinking of her family.
Rest in peace dear Rachna. 💔 cancercenter.arizona.edu/new…
Madison Conces, MD retweeted
Devastating news 💔
Rest in peace dear Rachna.
medicine.arizona.edu/news/20…
Madison Conces, MD retweeted
In Memoriam: Dominique Vervoort, MD, MPH, MBA (1994-2026) - CJC Open cjcopen.ca/article/S2589-790… 💔🙏
Madison Conces, MD retweeted
Awards time! The Oncologist of the Year Award goes to @rachnatshroff and the Rising Star Award goes to Dr. Christine Ann Garcia. Congratulations to both!
Madison Conces, MD retweeted
Wow!! Powerful talks and even more powerful stories from these incredible superwomen leaders! 💪👏 #LEAD2026
A few pearls:
- Say yes even before you feel ready
- Leap and the net will appear
- Take care of your work family
- Learn through people
- Get intentionally uncomfortable
🙏 #TriciaKalwar @ndenduluri1 #JodiBrass @lynn_schuchter @AnaVManana @rachnatshroff @KatieLaiMD_MPH #MedEd #Womeninmedicine #womeninoncology #oncology #hematology @BioAscend
Madison Conces, MD retweeted
Team we are SO CLOSE!!! Let’s get this done! @ConquerCancerFd @ASCO @VaniamGroup @DeannavanGestel @UAZCancer
Madison Conces, MD retweeted
Electronic health records and messages have a major impact on physician workload - though often invisible and underestimated. Report @JCOOP_ASCO show that every patient EHR messages leads to ~7 internal in-basket messages. Contribution to burnout?
ascopubs.org/doi/10.1200/OP-…
Madison Conces, MD retweeted
Eric Miller Leads International Trial Exploring Total Ablative Therapy for Limited Metastatic Colorectal Cancer oncodaily.com/voices/eric-mi…











































